BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4714909)

  • 1. Isolation and some properties of an acid phosphatase from the plasma of the tasmanian devil, Sarcophilus harrisii (Marsupialia: Dasyuridae).
    Sallis JD; Parsons RS; Guiler ER
    Comp Biochem Physiol B; 1973 Apr; 44(4):971-80. PubMed ID: 4714909
    [No Abstract]   [Full Text] [Related]  

  • 2. The distribution of acid phosphatase in the Tasmanian devil, Sarcophilus harrisii (Marsupialia; Dasyuridae).
    Parsons RS; Heddle RW; Guiler ER
    Comp Biochem Physiol B; 1971 Jun; 39(2):219-26. PubMed ID: 5119902
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonprostatic formalin-resistant acid phosphatase in the Tasmanian devil.
    Parsons RS; Guiler ER
    Clin Chem; 1972 Aug; 18(8):867. PubMed ID: 5043275
    [No Abstract]   [Full Text] [Related]  

  • 4. Body temperatures in the Tasmanian devil, Sarcophilus harrisii (Harsupialia: Dasyuridae).
    Guiler ER; Heddle RW
    Comp Biochem Physiol A Comp Physiol; 1974 Mar; 47(3):981-9. PubMed ID: 4156267
    [No Abstract]   [Full Text] [Related]  

  • 5. A sulfate-dependent acid phosphatase of Thiobacillus thiooxidans. Its partial purification and some properties.
    Tominaga N; Mori T
    J Biochem; 1974 Aug; 76(2):397-408. PubMed ID: 4609973
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary mycobacteriosis caused by Mycobacterium intracellulare in a Tasmanian devil (Sarcophilus harrisii).
    Michael SA; Sangster CR
    Aust Vet J; 2010 Jul; 88(7):280-2. PubMed ID: 20579036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptospirosis in Tasmanian Devils ( Sarcophilus harrisii ) in Tasmania, 2008-12.
    Wynwood SJ; Burns MA; Graham GC; Weier SL; McKay DB; Peck S; Craig SB
    J Wildl Dis; 2016 Jul; 52(3):636-41. PubMed ID: 27243149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
    Phalen DN; Frimberger AE; Peck S; Pyecroft S; Harmsen C; Lola S; Moore AS
    Vet J; 2015 Dec; 206(3):312-6. PubMed ID: 26538144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii).
    Wait LF; Fox S; Peck S; Power ML
    PLoS One; 2017; 12(4):e0174994. PubMed ID: 28423030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the blood of the Tasmanian devil.
    Parsons RS; Heddle RW; Flux WG; Guiler ER
    Comp Biochem Physiol; 1970 Jan; 32(2):345-51. PubMed ID: 4190500
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii).
    Loh R; Hayes D; Mahjoor A; O'Hara A; Pyecroft S; Raidal S
    Vet Pathol; 2006 Nov; 43(6):896-903. PubMed ID: 17099146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary histories of transposable elements in the genome of the largest living marsupial carnivore, the Tasmanian devil.
    Gallus S; Hallström BM; Kumar V; Dodt WG; Janke A; Schumann GG; Nilsson MA
    Mol Biol Evol; 2015 May; 32(5):1268-83. PubMed ID: 25633377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCCURRENCE OF PASTEURELLACEAE BACTERIA IN THE ORAL CAVITY OF THE TASMANIAN DEVIL (SARCOPHILUS HARRISII).
    Brix L; Hansen MJ; Kelly A; Bertelsen MF; Bojesen AM
    J Zoo Wildl Med; 2015 Jun; 46(2):241-5. PubMed ID: 26056874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEMATOLOGICAL AND SERUM BIOCHEMICAL VALUES IN ANESTHETIZED CAPTIVE TASMANIAN DEVILS (SARCOPHILUS HARRISII).
    Hope KL; Peck S
    J Zoo Wildl Med; 2016 Jun; 47(2):564-72. PubMed ID: 27468030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitrification as a method for genome resource banking oocytes from the endangered Tasmanian devil (Sarcophilus harrisii).
    Czarny NA; Rodger JC
    Cryobiology; 2010 Jun; 60(3):322-5. PubMed ID: 20219455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antibody V segment diversity in the Tasmanian devil (Sarcophilus harrisii).
    Ujvari B; Belov K
    Vet Immunol Immunopathol; 2015 Oct; 167(3-4):156-65. PubMed ID: 26300316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satanicoptes armatus, n. gen., n.sp. (Astigmata: Sarcoptidae), a new mite producing mange in the Tasmanian devil (Sarcophilus harrisii Boitard).
    Fain A; Laurence BR
    J Med Entomol; 1975 Oct; 12(4):415-7. PubMed ID: 1195287
    [No Abstract]   [Full Text] [Related]  

  • 18. The low-molecular-weight acid phosphatase from bovine liver: isolation, amino acid composition, and chemical modification studies.
    Lawrence GL; van Etten RL
    Arch Biochem Biophys; 1981 Jan; 206(1):122-31. PubMed ID: 7212711
    [No Abstract]   [Full Text] [Related]  

  • 19. A 'devil' of a problem.
    Hansen VL; Miller RD
    Elife; 2018 Aug; 7():. PubMed ID: 30103857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
    Hubert JN; Zerjal T; Hospital F
    PLoS One; 2018; 13(8):e0201838. PubMed ID: 30102725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.